READER QUESTIONS:
Use J9999 for Temozolomide for Now
Published on Mon Oct 26, 2009
Question: What J code should I report for intravenous temozolomide? New Jersey Subscriber Answer: HCPCS doesn't currently offer a specific code for temozolomide, so you should report J9999 (Not otherwise classified, antineoplastic drugs). Stay tuned: Temozolomide, sold as Temodar, had a spot in the April 2009 HCPCS Public Meeting agenda (
www.cms.hhs.gov/MedHCPCSGenInfo/Downloads/DrugBiologicalsandRadiopharmaceuticals-Agenda.pdf). CMS's preliminary decision was to create a J code for "Injection, Temozolomide, 1mg." Who needs it: Oncologists use temozolomide for adult patients with glioblastoma multiforme (coded as a malignant neoplasm based on site) and refractory anaplastic astrocytoma (also coded as malignant neoplasm by site).
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
